Login / Signup

Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study.

Paul GlueShona NeehoffBen BeagleholeShabah ShadliNeil McNaughtonNatalie J Hughes-Medlicott
Published in: Journal of psychopharmacology (Oxford, England) (2024)
Our findings add to the literature confirming ketamine's activity against depressive and anxiety symptoms in patients with TRD.
Keyphrases
  • major depressive disorder
  • bipolar disorder
  • double blind
  • pain management
  • sleep quality
  • systematic review
  • clinical trial
  • placebo controlled
  • stress induced
  • study protocol
  • phase ii
  • open label